# Unilever plc: financial statements, quarterly

UL · NYSE · CIK 217410 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ul.md) · [Financials](/companies/ul/financials.md) · [Filings](/companies/ul/filings.md) · [Insiders](/companies/ul/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ul/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | [3.4](/filings/0001193125-18-074695.md) | [3.3](/filings/0001193125-19-070426.md) | [3.2](/filings/0001193125-20-067343.md) | [4.2](/filings/0001193125-21-075770.md) | [5.5](/filings/0000217410-22-000009.md) | [3.4](/filings/0000217410-23-000016.md) | [4.3](/filings/0000217410-24-000017.md) | [4.2](/filings/0000217410-25-000015.md) | [6.1](/filings/0000217410-26-000007.md) | [3.9](/filings/0000217410-26-000007.md) |
| Current assets | $bn | not reported | not reported | [13.9](/filings/0001193125-18-074695.md) | [17.0](/filings/0001193125-19-070426.md) | [15.5](/filings/0001193125-20-067343.md) | [16.4](/filings/0001193125-21-075770.md) | [16.2](/filings/0000217410-22-000009.md) | [17.4](/filings/0000217410-23-000016.md) | [19.2](/filings/0000217410-24-000017.md) | [17.9](/filings/0000217410-25-000015.md) | [19.2](/filings/0000217410-26-000007.md) | [17.1](/filings/0000217410-26-000007.md) |
| Total assets | $bn | not reported | not reported | [56.4](/filings/0001193125-18-074695.md) | [60.3](/filings/0001193125-19-070426.md) | [61.1](/filings/0001193125-20-067343.md) | [64.8](/filings/0001193125-21-075770.md) | [67.7](/filings/0000217410-22-000009.md) | [75.1](/filings/0000217410-23-000016.md) | [77.8](/filings/0000217410-24-000017.md) | [75.3](/filings/0000217410-25-000015.md) | [79.8](/filings/0000217410-26-000007.md) | [70.5](/filings/0000217410-26-000007.md) |
| Current liabilities | $bn | not reported | not reported | [20.6](/filings/0001193125-18-074695.md) | [23.2](/filings/0001193125-19-070426.md) | [20.2](/filings/0001193125-20-067343.md) | [21.0](/filings/0001193125-21-075770.md) | [20.6](/filings/0000217410-22-000009.md) | [24.8](/filings/0000217410-23-000016.md) | [25.4](/filings/0000217410-24-000017.md) | [23.5](/filings/0000217410-25-000015.md) | [25.2](/filings/0000217410-26-000007.md) | [21.7](/filings/0000217410-26-000007.md) |
| Total liabilities | $bn | not reported | not reported | [39.4](/filings/0001193125-18-074695.md) | [45.9](/filings/0001193125-19-070426.md) | [49.0](/filings/0001193125-20-067343.md) | [50.9](/filings/0001193125-21-075770.md) | [50.0](/filings/0000217410-22-000009.md) | [55.3](/filings/0000217410-23-000016.md) | [56.1](/filings/0000217410-24-000017.md) | [54.5](/filings/0000217410-25-000015.md) | [57.2](/filings/0000217410-26-000007.md) | [52.9](/filings/0000217410-26-000007.md) |
| Shareholders' equity | $bn | [14.3](/filings/0001193125-18-074695.md) | [16.1](/filings/0001193125-19-070426.md) | [16.4](/filings/0001193125-18-074695.md) | [13.6](/filings/0001193125-19-070426.md) | [11.4](/filings/0001193125-20-067343.md) | [13.2](/filings/0001193125-21-075770.md) | [15.3](/filings/0000217410-22-000009.md) | [17.1](/filings/0000217410-23-000016.md) | [19.0](/filings/0000217410-24-000017.md) | [18.1](/filings/0000217410-25-000015.md) | [20.0](/filings/0000217410-26-000007.md) | [15.5](/filings/0000217410-26-000007.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 2,181,005,247 at 2025-12-31, from the cover of the [20-F filed 2026-03-12](/filings/0000217410-26-000007.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.